Synthetic Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYN and buy or sell other stocks, ETFs, and their options commission-free!About SYN
Theriva Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-020 and SYN-004.
CEOSteven A. Shallcross, MBA, CPA
CEOSteven A. Shallcross, MBA, CPA
Employees22
Employees22
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2001
Founded2001
Employees22
Employees22
SYN Key Statistics
Market cap1.37M
Market cap1.37M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume18.49K
Average volume18.49K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$12.28
52 Week high$12.28
52 Week low$0.9563
52 Week low$0.9563